GlassScriptPhysician profile
Mary Beth Johnson
NPI 1104085497
$29,539.29
in general payments reported to CMS, 2019-2025
25 companies · $8,551 in 2025
The $8,551 reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.97 · 2022: $6,912 · 2023: $6,970 · 2024: $7,011 · 2025: $8,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $21K · Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $20,540.99 |
| Food and Beverage | $1,990.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $27,027.27 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $579.35 | 2022-2025 | Veozah |
| Abbvie INC. | $408.84 | 2021-2024 | |
| Exeltis, USA INC. | $275.17 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $153.29 | 2022-2023 | |
| Biogen, INC. | $130.87 | 2024-2025 | Zurzuvae |
| Acella Pharmaceuticals, LLC | $130.01 | 2023 | NP Thyroid 60 |
| Galderma Laboratories, L.P. | $104.84 | 2021-2022 | |
| Hologic Sales and Service, LLC | $100.22 | 2022-2025 | Aptima, Thinprep 2000 Processor, Third Wave |
| Daiichi Sankyo INC. | $84.60 | 2022-2024 | Injectafer |
| Coopersurgical, INC. | $69.90 | 2022-2023 | Paragard T 380a |
| Myovant Sciences INC. | $68.93 | 2021-2022 | |
| Pfizer INC. | $64.82 | 2022-2025 | |
| Axonics, INC. | $54.71 | 2023 | Axonics, Bulkamid |
| Novo Nordisk INC | $50.45 | 2022-2023 | Wegovy |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $49.35 | 2023-2024 | Harmonic |
| Biohaven Pharmaceutical Holding Company LTD. | $39.49 | 2022 | |
| Merck Sharp & Dohme LLC | $30.43 | 2022-2023 | Gardasil 9 |
| Octapharma USA, INC. | $27.74 | 2025 | Fibryga |
| Exact Sciences Corporation | $17.10 | 2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $16.11 | 2023 | Quviviq |
| Medline Industries LP | $15.17 | 2022 | |
| Medtronic, INC. | $14.51 | 2022 | |
| Sumitomo Pharma America, INC. | $13.45 | 2024 | Myfembree |
| Amgen INC. | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.